다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Bone, v.105, 2017년, pp.276 - 286
Marty, Eric (Corresponding author.) , Liu, Yi , Samuel, Andre , Or, Omer , Lane, Joseph
AI-Helper
Abstract Sarcopenia is defined as an age associated decline in skeletal muscle mass. The pathophysiology of sarcopenia is multifactorial, with decreased caloric intake, muscle fiber denervation, intracellular oxidative stress, hormonal decline, and enhanced myostatin signaling all thought to contri...
Table 2 2008 Population Division Projections of the Population by Selected Age Groups and Sex for the United States: 2010 to 2050 (NP2008-T2)
Age Ageing Patel 42 3 378 2013 10.1093/ageing/afs197 Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)
Am. J. Clin. Nutr. 50 5 Suppl 1121 1989
Curr. Osteoporos. Rep. Girgis 12 2 142 2014 10.1007/s11914-014-0204-5 Therapies for musculoskeletal disease: can we treat two birds with one stone?
Med. Sci. Sports Exerc. Frost 32 5 911 2000 10.1097/00005768-200005000-00006 Muscle, bone, and the Utah paradigm: a 1999 overview
J. Musculoskelet. Neuronal Interact. Frost 1 3 185 2001 The Utah paradigm on animal models of skeletal disorders: quo vadis?
J. Bone Miner. Res. Edwards 28 11 2295 2013 10.1002/jbmr.1972 Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study
J. Bone Miner. Metab. Miyakoshi 31 5 556 2013 10.1007/s00774-013-0443-z Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis
Korean J. Fam. Med. Go 34 4 281 2013 10.4082/kjfm.2013.34.4.281 Association between sarcopenia, bone density, and health-related quality of life in Korean men
Maturitas Sjoblom 75 2 175 2013 10.1016/j.maturitas.2013.03.016 Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia
J. Clin. Densitom. Lima 12 1 35 2009 10.1016/j.jocd.2008.10.003 Fat-free mass, strength, and sarcopenia are related to bone mineral density in older women
Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Verschueren 24 1 87 2013 10.1007/s00198-012-2057-z Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men
Arch. Gerontol. Geriatr. Di Monaco 55 2 e48 2012 10.1016/j.archger.2012.05.002 Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients
Arch. Gerontol. Geriatr. Di Monaco 52 1 71 2011 10.1016/j.archger.2010.02.002 Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture
Aging Clin. Exp. Res. Iolascon 25 Suppl. 1 S129 2013 10.1007/s40520-013-0102-1 Sarcopenia in women with vertebral fragility fractures
Clin. Calcium Hida 23 5 707 2013 Fall risk and fracture. Diagnosing sarcopenia and sarcopenic leg to prevent fall and fracture: its difficulty and pit falls
Eur. Spine J. Hida 25 11 3424 2016 10.1007/s00586-015-3805-5 Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women
J. Am. Med. Dir. Assoc. Yu 15 8 551 2014 10.1016/j.jamda.2014.02.005 Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study
Curr. Opin. Rheumatol. Walston 24 6 623 2012 10.1097/BOR.0b013e328358d59b Sarcopenia in older adults
J. Phys. Act. Health Marquez 8 Suppl. 2 S161 2011 10.1123/jpah.8.s2.s161 Physical activity of urban community-dwelling older Latino adults
Clin. Nutr. Nieuwenhuizen 29 2 160 2010 10.1016/j.clnu.2009.09.003 Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake
Am. J. Clin. Nutr. Houston 87 1 150 2008 10.1093/ajcn/87.1.150 Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study
J. Cachex. Sarcopenia Muscle Morley 5 4 253 2014 10.1007/s13539-014-0161-y Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014
Mech. Ageing Dev. Baumgartner 107 2 123 1999 10.1016/S0047-6374(98)00130-4 Predictors of skeletal muscle mass in elderly men and women
Age Ageing Samson 29 3 235 2000 10.1093/ageing/29.3.235 Relationships between physical performance measures, age, height and body weight in healthy adults
Exerc. Sport Sci. Rev. Lowe 38 2 61 2010 10.1097/JES.0b013e3181d496bc Mechanisms behind estrogen's beneficial effect on muscle strength in females
J. Endocrinol. Perrini 205 3 201 2010 10.1677/JOE-09-0431 The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis
Mech. Ageing Dev. Li 124 7 771 2003 10.1016/S0047-6374(03)00124-6 Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle
Physiol. Genomics Dennis 32 3 393 2008 10.1152/physiolgenomics.00191.2007 Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise
Int. J. Mol. Sci. Meng 11 4 1509 2010 10.3390/ijms11041509 Oxidative stress, molecular inflammation and sarcopenia
Age (Dordr.) Karasik 33 1 49 2011 10.1007/s11357-010-9159-3 How pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of aging
Int. J. Biochem. Cell Biol. Han 45 10 2333 2013 10.1016/j.biocel.2013.05.019 Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Nature McPherron 387 6628 83 1997 10.1038/387083a0 Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
J. Cell. Physiol. Siriett 209 3 866 2006 10.1002/jcp.20778 Prolonged absence of myostatin reduces sarcopenia
J. Nutr. Health Aging Yarasheski 6 5 343 2002 Serum myostatin-immunoreactive protein is increased in 60-92year old women and men with muscle wasting
Exp. Gerontol. Nilwik 48 5 492 2013 10.1016/j.exger.2013.02.012 The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size
Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Lang 21 4 543 2010 10.1007/s00198-009-1059-y Sarcopenia: etiology, clinical consequences, intervention, and assessment
Muscle Nerve Vandervoort 25 1 17 2002 10.1002/mus.1215 Aging of the human neuromuscular system
Eur. J. Appl. Physiol. Kostka 95 2-3 140 2005 10.1007/s00421-005-1390-8 Quadriceps maximal power and optimal shortening velocity in 335 men aged 23-88years
Aging (Albany NY) Ben-Avraham 2017 Correction: the complex genetics of gait speed: genome-wide meta-analysis approach
Nat. Commun. Willems 8 2017 Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness
Nat. Commun. Zillikens 8 1 80 2017 10.1038/s41467-017-00031-7 Large meta-analysis of genome-wide association studies identifies five loci for lean body mass
Nutr. Res. Batsis 35 12 1031 2015 10.1016/j.nutres.2015.09.003 Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004
Age Ageing Cruz-Jentoft 43 6 748 2014 10.1093/ageing/afu115 Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
J. Gerontol. A Biol. Sci. Med. Sci. Han 71 4 529 2016 10.1093/gerona/glv108 Prevalence and factors associated with sarcopenia in suburb-dwelling older chinese using the Asian Working Group for sarcopenia definition
Geriatr Gerontol Int Wu 14 Suppl. 1 52 2014 10.1111/ggi.12193 Epidemiology of sarcopenia among community-dwelling older adults in Taiwan: a pooled analysis for a broader adoption of sarcopenia assessments
J. Am. Geriatr. Soc. Melton 48 6 625 2000 10.1111/j.1532-5415.2000.tb04719.x Epidemiology of sarcopenia
Z. Gerontol. Geriatr. Spira 49 2 94 2016 10.1007/s00391-015-0886-z Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II)
J. Am. Med. Dir. Assoc. Lee 14 7 528e1 2013 10.1016/j.jamda.2013.03.019 Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study
Arch. Gerontol. Geriatr. Zeng 60 1 118 2015 10.1016/j.archger.2014.08.010 Differences in body composition and physical functions associated with sarcopenia in Chinese elderly: reference values and prevalence
Age (Dordr.) Tay 37 6 121 2015 10.1007/s11357-015-9860-3 Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults
Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Figueiredo 25 2 589 2014 10.1007/s00198-013-2455-x Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the Sao Paulo Ageing & Health Study (SPAH)
J. Gerontol. A Biol. Sci. Med. Sci. Bianchi 2017 10.1093/gerona/glw343 Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study
Maturitas Senior 82 4 418 2015 10.1016/j.maturitas.2015.08.006 Prevalence and risk factors of sarcopenia among adults living in nursing homes
Hong Kong Medical Journal=Xianggang yi xue za zhi Ho 22 1 23 2016 Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors
Clin. Interv. Aging Kemmler 10 1565 2015 10.2147/CIA.S89585 Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70years and older living in the community: results of the FORMoSA study
Am. J. Epidemiol. Baumgartner 147 8 755 1998 10.1093/oxfordjournals.aje.a009520 Epidemiology of sarcopenia among the elderly in New Mexico
Geriatr Gerontol Int Kim 16 Suppl. 1 110 2016 10.1111/ggi.12723 Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults
J. Gerontol. A Biol. Sci. Med. Sci. Landi 67 1 48 2012 10.1093/gerona/glr035 Prevalence and risk factors of sarcopenia among nursing home older residents
J. Am. Geriatr. Soc. Newman 51 11 1602 2003 10.1046/j.1532-5415.2003.51534.x Sarcopenia: alternative definitions and associations with lower extremity function
J. Am. Geriatr. Soc. Janssen 50 5 889 2002 10.1046/j.1532-5415.2002.50216.x Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability
Am. J. Prev. Med. Castillo 25 3 226 2003 10.1016/S0749-3797(03)00197-1 Sarcopenia in elderly men and women: the Rancho Bernardo study
Age Ageing Cruz-Jentoft 39 4 412 2010 10.1093/ageing/afq034 P. European Working Group on Sarcopenia in Older, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
Med. Sci. Monit. Bolanowski 7 5 1029 2001 Assessment of human body composition using dual-energy X-ray absorptiometry and bioelectrical impedance analysis
Int. J. Body Compos. Res. Beeson 8 2 45 2010 Comparison of body composition by bioelectrical impedance analysis and dual-energy X-ray absorptiometry in Hispanic diabetics
J. Obes. Miyatani 2012 953060 2012 10.1155/2012/953060 Bioelectrical impedance and dual-energy X-ray absorptiometry assessments of changes in body composition following exercise in patients with type 2 diabetes mellitus
Ann. N. Y. Acad. Sci. Lukaski 904 154 2000 10.1111/j.1749-6632.2000.tb06440.x Assessing regional muscle mass with segmental measurements of bioelectrical impedance in obese women during weight loss
Proc. Nutr. Soc. Heymsfield 74 4 355 2015 10.1017/S0029665115000129 Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia
Am. J. Clin. Nutr. Sun 81 1 74 2005 10.1093/ajcn/81.1.74 Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population
J. Am. Med. Dir. Assoc. Fielding 12 4 249 2011 10.1016/j.jamda.2011.01.003 Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia
Clin. Nutr. Muscaritoli 29 2 154 2010 10.1016/j.clnu.2009.12.004 Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"
J. Am. Med. Dir. Assoc. Chen 15 2 95 2014 10.1016/j.jamda.2013.11.025 Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia
Calcif. Tissue Int. Cooper 93 3 201 2013 10.1007/s00223-013-9757-z Tools in the assessment of sarcopenia
J. Gerontol. A Biol. Sci. Med. Sci. Studenski 69 5 547 2014 10.1093/gerona/glu010 The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates
J. Gerontol. A Biol. Sci. Med. Sci. Dam 69 5 584 2014 10.1093/gerona/glu013 An evidence-based comparison of operational criteria for the presence of sarcopenia
JAMA Nih Consensus Development Panel on Osteoporosis Prevention, Therapy 285 6 785 2001 10.1001/jama.285.6.785 Osteoporosis prevention, diagnosis, and therapy
Ageing Res. Rev. Tagliaferri 21 55 2015 10.1016/j.arr.2015.03.002 Muscle and bone, two interconnected tissues
J. Bone Miner. Res. Karasik 23 6 788 2008 10.1359/jbmr.080218 Genetics of the musculoskeletal system: a pleiotropic approach
J. Bone Miner. Res. Wang 23 3 447 2008 10.1359/jbmr.071033 Bivariate whole genome linkage analyses for total body lean mass and BMD
J. Bone Miner. Res. Deng 22 6 808 2007 10.1359/jbmr.070303 Bivariate whole genome linkage analysis for femoral neck geometric parameters and total body lean mass
Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Hirschfeld 2017 10.1007/s00198-017-4151-8 Osteosarcopenia: where bone, muscle, and fat collide
J. Am. Med. Dir. Assoc. Huo 16 4 290 2015 10.1016/j.jamda.2014.10.018 Phenotype of osteosarcopenia in older individuals with a history of falling
J. Cell. Biochem. Kawao 116 5 687 2015 10.1002/jcb.25040 Interactions between muscle tissues and bone metabolism
Aging Clin. Exp. Res. Drey 28 5 895 2016 10.1007/s40520-015-0494-1 Osteosarcopenia is more than sarcopenia and osteopenia alone
J. Nutr. Health Aging Huo 19 4 474 2015 10.1007/s12603-014-0543-z Comprehensive nutritional status in sarco-osteoporotic older fallers
Bone Lang 42 4 798 2008 10.1016/j.bone.2007.12.002 Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture
J. Clin. Densitom. Binkley 12 4 413 2009 10.1016/j.jocd.2009.06.004 Beyond FRAX: it's time to consider "sarco-osteopenia"
Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Binkley 24 12 2955 2013 10.1007/s00198-013-2427-1 What's in a name revisited: should osteoporosis and sarcopenia be considered components of “dysmobility syndrome?”
Clin. Interv. Aging Hill 12 145 2017 10.2147/CIA.S102961 Dysmobility syndrome: current perspectives
J. Gerontol. A Biol. Sci. Med. Sci. Fried 56 3 M146 2001 10.1093/gerona/56.3.M146 Frailty in older adults: evidence for a phenotype
Bone Frisoli 48 4 952 2011 10.1016/j.bone.2010.12.025 Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women's Health and Aging Study (WHAS) II
J. Am. Med. Dir. Assoc. Reijnierse 17 4 371e7 2016 10.1016/j.jamda.2016.01.013 Common ground? The concordance of sarcopenia and frailty definitions
Clin. Geriatr. Med. Waters 27 3 401 2011 10.1016/j.cger.2011.03.007 Sarcopenia and obesity
J. Sports Med. Phys. Fitness Duvigneaud 48 2 201 2008 Relationship of obesity with physical activity, aerobic fitness and muscle strength in Flemish adults
Curr. Opin. Clin. Nutr. Metab. Care Stenholm 11 6 693 2008 10.1097/MCO.0b013e328312c37d Sarcopenic obesity: definition, cause and consequences
J. Am. Geriatr. Soc. Visser 50 5 897 2002 10.1046/j.1532-5415.2002.50217.x Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study
Am. J. Clin. Nutr. Rolland 89 6 1895 2009 10.3945/ajcn.2008.26950 Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study
J. Am. Geriatr. Soc. Davison 50 11 1802 2002 10.1046/j.1532-5415.2002.50508.x Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III
J. Am. Geriatr. Soc. Batsis 61 6 974 2013 10.1111/jgs.12260 Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004
Clin. Nutr. Evans 27 6 793 2008 10.1016/j.clnu.2008.06.013 Cachexia: a new definition
Gerontology Ali 60 4 294 2014 10.1159/000356760 Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review
Curr. Opin. Pharmacol. Argiles 22 100 2015 10.1016/j.coph.2015.04.003 Cachexia and sarcopenia: mechanisms and potential targets for intervention
Clin. Nutr. Landi 31 5 652 2012 10.1016/j.clnu.2012.02.007 Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Bone Ji 2014 Sarcopenia in patients scheduled to undergo orthopaedic surgery
Ann. Surg. Oncol. Wang 23 2 556 2016 10.1245/s10434-015-4887-3 Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study
Orthopedics Bokshan 39 6 e1159 2016 10.3928/01477447-20160811-02 Effect of Sarcopenia on Postoperative Morbidity and Mortality After Thoracolumbar Spine Surgery
Ann. Surg. Englesbe 256 2 255 2012 10.1097/SLA.0b013e31826028b1 Analytic morphomics, core muscle size, and surgical outcomes
J. Am. Coll. Surg. Englesbe 211 2 271 2010 10.1016/j.jamcollsurg.2010.03.039 Sarcopenia and mortality after liver transplantation
J. Nutr. Health Aging Arango-Lopera 17 3 259 2013 10.1007/s12603-012-0434-0 Mortality as an adverse outcome of sarcopenia
J. Am. Coll. Surg. Sheetz 217 5 813 2013 10.1016/j.jamcollsurg.2013.04.042 Cost of major surgery in the sarcopenic patient
J. Am. Geriatr. Soc. Kim 60 1 16 2012 10.1111/j.1532-5415.2011.03776.x Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial
J. Am. Med. Dir. Assoc. Bauer 16 9 740 2015 10.1016/j.jamda.2015.05.021 Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial
J. Am. Med. Dir. Assoc. Cramer 17 11 1044 2016 10.1016/j.jamda.2016.08.009 Impacts of high-protein oral nutritional supplements among malnourished men and women with sarcopenia: a multicenter, randomized, double-blinded, controlled trial
J. Clin. Endocrinol. Metab. Beaudart 99 11 4336 2014 10.1210/jc.2014-1742 The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials
Endocrine Candow 45 3 354 2014 10.1007/s12020-013-0070-4 Creatine supplementation and aging musculoskeletal health
Proc. Nutr. Soc. Hickson 74 4 378 2015 10.1017/S0029665115002049 Nutritional interventions in sarcopenia: a critical review
J. Am. Geriatr. Soc. Suetta 52 12 2016 2004 10.1111/j.1532-5415.2004.52557.x Resistance training in the early postoperative phase reduces hospitalization and leads to muscle hypertrophy in elderly hip surgery patients-a controlled, randomized study
Geriatr. Nurs. Hassan 37 2 116 2016 10.1016/j.gerinurse.2015.11.001 Impact of resistance training on sarcopenia in nursing care facilities: a pilot study
J. Nutr. Health Aging Liu 18 1 59 2014 10.1007/s12603-013-0369-0 The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P)
Clin. Rehabil. Lau 25 11 975 2011 10.1177/0269215511405078 The effects of whole body vibration therapy on bone mineral density and leg muscle strength in older adults: a systematic review and meta-analysis
Scand. J. Med. Sci. Sports von Stengel 22 1 119 2012 10.1111/j.1600-0838.2010.01126.x Effect of whole-body vibration on neuromuscular performance and body composition for females 65 years and older: a randomized-controlled trial
Geriatr Gerontol Int Wei 2016 10.1111/ggi.12878 Optimal frequency/time combination of whole-body vibration training for improving muscle size and strength of people with age-related muscle loss (sarcopenia): A randomized controlled trial
J. Cachex. Sarcopenia Muscle Potsch 5 2 149 2014 10.1007/s13539-013-0125-7 The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
Nat. Rev. Drug Discov. Cohen 14 1 58 2015 10.1038/nrd4467 Muscle wasting in disease: molecular mechanisms and promising therapies
J. Cachex. Sarcopenia Muscle Stewart Coats 7 3 355 2016 10.1002/jcsm.12126 Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
J. Clin. Invest. Porporato 123 2 611 2013 Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice
Endocrinology Tamaki 156 10 3638 2015 10.1210/en.2015-1353 Improvement of physical decline through combined effects of muscle enhancement and mitochondrial activation by a gastric hormone ghrelin in male 5/6Nx CKD model mice
J. Cachex. Sarcopenia Muscle Chen 6 2 132 2015 10.1002/jcsm.12023 Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved
J. Clin. Endocrinol. Metab. White 94 4 1198 2009 10.1210/jc.2008-0632 Effects of an oral growth hormone secretagogue in older adults
PLoS One Miki 7 5 2012 10.1371/journal.pone.0035708 Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial
Lancet Oncol. Temel 17 4 519 2016 10.1016/S1470-2045(15)00558-6 Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
Int. J. Cardiol. von Haehling 144 3 347 2010 10.1016/j.ijcard.2010.05.042 Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference
Clin. Sci. (Lond.) Sipila 101 2 147 2001 10.1042/cs1010147 Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study
Clin. Sci. (Lond.) Armstrong 91 6 685 1996 10.1042/cs0910685 Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women
J. Gerontol. A Biol. Sci. Med. Sci. Greising 64 10 1071 2009 10.1093/gerona/glp082 Hormone therapy and skeletal muscle strength: a meta-analysis
Eur. J. Med. Tiidus 43 2 109 2011 Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies
J. Appl. Physiol. (1985) Ronkainen 107 1 25 2009 10.1152/japplphysiol.91518.2008 Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs
J. Appl. Physiol. (1985) Dieli-Conwright 107 5 1381 2009 10.1152/japplphysiol.00590.2009 Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women
JAMA Chlebowski 289 24 3243 2003 10.1001/jama.289.24.3243 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial
Clin. Interv. Aging Burton 5 217 2010 Optimal management of sarcopenia
J. Endocrinol. Bhasin 170 1 27 2001 10.1677/joe.0.1700027 Proof of the effect of testosterone on skeletal muscle
J. Appl. Physiol. (1985) Pires-Oliveira 108 2 266 2010 10.1152/japplphysiol.00490.2009 Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo
J. Clin. Endocrinol. Metab. Fitts 100 2 E223 2015 10.1210/jc.2014-2759 Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males
Menopause Huang 21 6 612 2014 10.1097/GME.0000000000000093 Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial
J. Am. Coll. Cardiol. Iellamo 56 16 1310 2010 10.1016/j.jacc.2010.03.090 Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study
J. Gerontol. A Biol. Sci. Med. Sci. Calof 60 11 1451 2005 10.1093/gerona/60.11.1451 Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials
BMC Med. Xu 11 108 2013 10.1186/1741-7015-11-108 Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
J. Am. Soc. Nephrol. Johansen 17 8 2307 2006 10.1681/ASN.2006010034 Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial
Add-on study for protocol G200802 (NCT02463032): effect of GTx-024 on maximal neuromuscular function and lean body mass - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT02746328?term=enobosarm&rank=2>, 2017).
M.U.M. Center, The effect of nandrolone decanoate and leucine on muscle loss - tabular view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/record/NCT02376309>, 2017).
J Cachexia Sarcopenia Muscle Stewart Coats 2 4 201 2011 10.1007/s13539-011-0046-2
Muscle Nerve Attie 47 3 416 2013 10.1002/mus.23539 A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers
Lancet Diabetes Endocrinol. Becker 3 12 948 2015 10.1016/S2213-8587(15)00298-3 Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
J. Frailty Aging Woodhouse 5 1 62 2016 A Phase 2 randomized study investigating the efficacy and safety of myostatin antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty
A randomized, double-blind, placebo-controlled multi-center study to assess the effects of BYM338 on skeletal muscle in sarcopenic adults with mobility limitations, Last Access July 8, 2017 <https://www.novctrd.com/CtrdWeb/displaypdf.nov?trialresultid=13323> (2014).
BYM338 in Chronic Obstructive Pulmonary Disease (COPD) patients with cachexia - full text view - ClinicalTrials.gov. <https://www.clinicaltrials.gov/ct2/show/NCT01669174?cond=bimagrumab&draw=1&rank=6>, 2017).
Efficacy and safety of bimagrumab/BYM338 at 52weeks on physical function, muscle strength, mobility in sibm patients - full text view - ClinicalTrials.gov. <https://www.clinicaltrials.gov/ct2/show/NCT01925209?cond=bimagrumab&draw=1&rank=5>, 2017).
Muscle Nerve Campbell 2016 Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
Study of efficacy and safety of bimagrumab in patients after hip fracture surgery. <https://www.novartisclinicaltrials.com/TrialConnectWeb/aboutresult.nov?studyid=55051>, 2017).
Clinical trial to evaluate the efficacy, safety, and tolerability of BMS-986089 in ambulatory boys with duchenne muscular dystrophy - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT03039686?term=BMS-986089&rank=1>, 2017).
A phase 2 study to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of PF-06252616 in Duchenne muscular dystrophy - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT02310763?term=PF-06252616&rank=1>, 2017).
Cell Ruas 151 6 1319 2012 10.1016/j.cell.2012.10.050 A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy
Muscle Nerve Hinkle 32 6 775 2005 10.1002/mus.20416 Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
J. Am. Geriatr. Soc. Chien 56 9 1710 2008 10.1111/j.1532-5415.2008.01854.x Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan
Support Care Cancer Garcia 21 1 129 2013 10.1007/s00520-012-1500-1 Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
Ann. Intern. Med. Nass 149 9 601 2008 10.7326/0003-4819-149-9-200811040-00003 Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial
J. Gerontol. A Biol. Sci. Med. Sci. Frisoli 60 5 648 2005 10.1093/gerona/60.5.648 The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial
J. Cachex. Sarcopenia Muscle Dalton 2 3 153 2011 10.1007/s13539-011-0034-6 The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
Lancet Oncol. Dobs 14 4 335 2013 10.1016/S1470-2045(13)70055-X Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
Phase III study of the effect of GTx-024 on muscle wasting in patients with Non-small Cell Lung Cancer (NSCLC) - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT01355484?term=enobosarm&rank=9>, 2017).
J. Nutr. Health Aging Papanicolaou 17 6 533 2013 10.1007/s12603-013-0335-x A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
Clinical study of BYM338 for the treatment of unintentional weight loss in patients with cancer of the lung or the pancreas - full text view - ClinicalTrials.gov. <https://www.clinicaltrials.gov/ct2/show/NCT01433263?cond=bimagrumab&draw=1&rank=10>, 2017).
A phase 2 study of LY2495655 in participants with pancreatic cancer - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT01505530?term=LY2495655&rank=1>, 2017).
Study of the safety and efficacy of REGN1033 (SAR391786) in patients with sarcopenia - full text view - ClinicalTrials.gov. <https://clinicaltrials.gov/ct2/show/NCT01963598?term=regn1033&rank=3>, 2017).
Atara bio announces results from the phase 2 proof-of-concept PINTA 745 clinical trial for protein energy wasting in patients with end stage renal disease, last access July 8, 2017 <http://investors.atarabio.com//releasedetail.cfm?releaseid=946796> (2017).
Ann. Neurol. Wagner 63 5 561 2008 10.1002/ana.21338 A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.